Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Cardiol Angeiol (Paris) ; 68(1): 28-31, 2019 Feb.
Article in French | MEDLINE | ID: mdl-30290914

ABSTRACT

INTRODUCTION: High-risk pulmonary embolism (PE) accounts for 5% of total acute PE and is a life-threatening emergency requiring immediate therapeutic management by fibrinolysis. The objective of this work is to describe the experience of thrombolysis in high-risk PE in a cardiology department in Togo. PATIENTS AND METHODS: This is an analytical and descriptive study carried out in the cardiology department of the Campus teaching hospital of Lomé over a period of 5 years (August 2012 to July 2017) concerning patients hospitalized for high-risk mortality PE and having undergone streptokinase thrombolysis. RESULTS: Twenty-eight of the 102 PE were at high risk of mortality (27.5%). They were 9 men and 19 women with an average age of 61.9±14.1 years. The mean systolic blood pressure was 65mmHg and 50% of the patients were placed on dobutamine. Thrombolysis was performed in 22 of the 28 patients (78.6%). Eighteen patients had a short protocol and 4 a long protocol. The mortality rate was 32.1% or 13.6% in the thrombolysis PE versus 100% in the non-thrombolysis PE (P=0.01). Causes of death in thrombolysis were persistent shock (2 cases) at the end of thrombolysis and sudden death occurred 1 month after hospitalization. The average hospital stay was 18.8 days. CONCLUSION: The high-risk PE remains today a pathology burdened with heavy mortality. Thrombolysis remains the first treatment to reduce this mortality.


Subject(s)
Pulmonary Embolism/drug therapy , Pulmonary Embolism/mortality , Thrombolytic Therapy/statistics & numerical data , Adult , Aged , Cardiology Service, Hospital , Cardiotonic Agents/therapeutic use , Dobutamine/therapeutic use , Drug Administration Schedule , Female , Fibrinolytic Agents/administration & dosage , Hospitals, Teaching , Humans , Length of Stay/statistics & numerical data , Male , Middle Aged , Streptokinase/administration & dosage , Togo/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...